Companies / SOLV vs DXCM
SOLV vs DXCM: Solventum and Dexcom
Solventum (SOLV) reported $8.3B in revenue against a 18.7% net margin, while Dexcom (DXCM) reported $4.7B at a 17.9% net margin, most recently.
| Metric | SOLV | DXCM |
|---|---|---|
| Revenue | $8.3B | $4.7B |
| Net Income | $1.6B | $0.8B |
| Gross Margin | 53.5% | 60.1% |
| Operating Margin | 26.2% | 19.6% |
| EPS (Diluted) | $8.88 | $2.09 |
| Free Cash Flow | $-10.0M | $1.1B |
| Total Debt | $5.0B | $1.3B |
| P/E Ratio | 8.9× | 31.8× |
| P/B Ratio | 2.7× | 9.3× |
| Stock Price | $87.11 | $84.45 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| SOLV Revenue | $8.1B | $8.2B | $8.3B | $8.3B |
| DXCM Revenue | $2.9B | $3.6B | $4.0B | $4.7B |